Na Li

Emerging Roles of Ceramide in Cardiovascular Diseases

Daowen Wang, Yizhong Peng, N. Zhou, 2022, Aging and disease.

Clinical Implications of Nicorandil Combined with Trimetazidine in Patients with Coronary Heart Disease: A Real-World Observational Study

Lin Qiu, N. Zhou, Lan Shen, 2021, Advances in Therapy.

MicroRNA-495 Confers Increased Sensitivity to Chemotherapeutic Agents in Gastric Cancer via the Mammalian Target of Rapamycin (mTOR) Signaling Pathway by Interacting with Human Epidermal Growth Factor Receptor 2 (ERBB2)

Mei Han, N. Zhou, Yong Tang, 2018, Medical science monitor : international medical journal of experimental and clinical research.

RBM20, a Therapeutic Target to Alleviate Myocardial Stiffness via Titin Isoforms Switching in HFpEF

N. Zhou, Hongyang Shu, Na Li, 2022, Frontiers in Cardiovascular Medicine.

Pirfenidone alleviates cardiac fibrosis induced by pressure overload via inhibiting TGF‐β1/Smad3 signalling pathway

N. Zhou, Hongyang Shu, Na Li, 2022, Journal of cellular and molecular medicine.

COVID-19 and Cardiovascular Diseases: From Cellular Mechanisms to Clinical Manifestations

Zheng Wen, Daowen Wang, Yizhong Peng, 2023, Aging and disease.

Relationship between microRNA-27a and efficacy of neoadjuvant chemotherapy in gastric cancer and its mechanism in gastric cancer cell growth and metastasis

N. Zhou, Chunlei Xu, Hong Cheng, 2019, Bioscience reports.

Real-World Major Adverse Cardiovascular Events of Nicorandil and Nitrate in Coronary Heart Disease in Central China: A Retrospective Cohort Study

N. Zhou, Lan Shen, Juan Chen, 2023, Cardiology Discovery.

Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance

Jia Hua Cheng, Yan Wang, Yizhong Peng, 2023, Cardiovascular Diabetology.

Combination of Nicorandil and Beta-Adrenergic Receptor Blockers in Patients with Coronary Artery Disease: A Real-World Observational Study

Lin Qiu, Jia Hua Cheng, Hongyang Shu, 2023, Journal of cardiovascular pharmacology and therapeutics.